Sandbox:Maria: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 1: | Line 1: | ||
== Hepatitis | ==Hepatitis C== | ||
=== Epidemiology === | ===Epidemiology=== | ||
=== Fisiopathology === | ===Fisiopathology=== | ||
=== Clinical features === | ===Clinical features=== | ||
=== Management === | ===Management=== | ||
{| | {| | ||
|+'''Classification of Waldenstrom macroglobulinemia (WM) and Related Disorders''' | |+'''Classification of Waldenstrom macroglobulinemia (WM) and Related Disorders''' |
Revision as of 15:49, 1 October 2020
Hepatitis C
Epidemiology
Fisiopathology
Clinical features
Management
Criteria | Symptomatic WM | Asymptomatic WM | IgM-Related Disorders | MGUS |
---|---|---|---|---|
IgM monoclonal protein | + | + | + | + |
Bone marrow infiltration | + | + | - | - |
Symptoms attributable to IgM | + | - | + | - |
Symptoms attributable to tumor infiltration | + | - | - | - |
![](/images/e/ee/800px-Lymph_node_metastasis_from_neuroendocrine_tumor.jpg)
References
- ↑ Kiran U, Aggarwal S, Choudhary A, Uma B, Kapoor PM (2017). "The blalock and taussig shunt revisited". Ann Card Anaesth. 20 (3): 323–330. doi:10.4103/aca.ACA_80_17. PMC 5535574. PMID 28701598.